Dipna Pharmachem
add_icon

Dipna Pharmachem

13.83
-0.23
(-1.64%)
Market Cap
₹36.39 Cr
PE Ratio
38.00
Volume
12,000.00
Day High - Low
₹14.97 - ₹13.83
52W High-Low
₹26.31 - ₹7.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
36.39 Cr
EPS
0.41
PB Ratio
0.89
Book Value
15.76
EBITDA
3.40
Dividend Yield
0.00 %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
0.48
Forecast For
Actual

Company News

View All News
Caret
positive
Dipna Pharmachem Allots 22.44 Lakh Equity Shares Upon Warrant ConversionNov 29, 2025
Dipna Pharmachem's Board approved allotment of 22,44,000 equity shares at Rs. 13.05 each to non-promoter allottees Mr. Ashok Dilipkumar Jain and Ms. Kajal Ashok Jain upon conversion of convertible warrants, raising Rs. 2.20 crores. The company's paid-up equity share capital increased from Rs. 24.05 crores to Rs. 26.29 crores, with the newly issued shares ranking pari-passu with existing equity shares.
positive
Dipna Pharmachem Limited posted net profit of Rs. 141.10 lakhs for six months ended September 30, 2025, marking a 319% increase from Rs. 33.67 lakhs in the same period last year, with total income declining to Rs. 7,354.12 lakhs from Rs. 9,062.38 lakhs. The pharmaceutical trading company raised Rs. 18.93 crores through allotment of 5.80 crore convertible warrants in September 2025 for working capital requirements and general corporate purposes.
neutral
Dipna Pharmachem Limited Non-Executive Director Nirav Soni ResignsNov 19, 2025
Nirav Soni (DIN: 08317653) resigned from his position as Non-Executive Director of Dipna Pharmachem Limited effective November 19, 2025, citing pre-occupation with other work and assignments. The Board acknowledged his valuable contributions during his tenure, and Soni confirmed there are no material reasons for his resignation beyond those stated in his resignation letter.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,807.20
#1 4,33,607.82
40.88
#1 54,729.00
9.71
#1 10,980
2.89
61.05
6,430.00
1,70,696.30
67.22
9,712.00
18.67
2,191
35.10
49.41
3,799.00
1,28,575.42
59.98
11,539.40
6.99
1,911
30.46
60.62
1,512.30
1,22,156.65
22.14
28,409.50
7.12
5,291
3.71
47.64
1,273.50
1,06,288.06
#1 18.20
33,741.20
16.73
5,725
-0.38
57.95
2,081.80
95,087.16
21.59
22,909.50
13.74
3,306
#1 72.75
59.68
922.55
92,830.12
18.48
23,511.00
18.55
4,615
34.60
37.29
2,166.80
89,436.51
49.98
12,744.20
#1 20.90
2,007
-21.05
30.56
1,172.20
68,081.57
19.89
32,345.60
9.43
3,484
3.81
45.41
5,626.00
67,267.27
27.77
13,458.30
3.70
2,216
10.98
48.53
Growth Rate
Revenue Growth
-23.98 %
Net Income Growth
-9.09 %
Cash Flow Change
-69.56 %
ROE
-12.46 %
ROCE
6.30 %
EBITDA Margin (Avg.)
32.06 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
17
20
31
31
73
100
164
125
0
Expenses
17
20
31
31
71
98
161
122
0
EBITDA
0
0
0
0
2
2
3
3
0
Operating Profit %
0 %
0 %
0 %
1 %
3 %
2 %
2 %
3 %
0 %
Depreciation
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
1
1
2
2
0
Profit Before Tax
0
0
0
0
2
1
1
1
0
Tax
0
0
0
0
0
1
0
0
0
Net Profit
0
0
0
0
1
1
1
1
0
EPS in ₹
17.27
9.15
16.86
6.91
333.39
0.76
0.45
0.41
0.00

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
11
14
18
25
36
78
133
132
Fixed Assets
0
0
0
0
0
0
0
0
Current Assets
11
14
18
25
36
78
133
132
Capital Work in Progress
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
Other Assets
11
14
18
25
36
78
133
132
Total Liabilities
11
14
18
25
36
78
133
132
Current Liabilities
11
14
18
21
29
42
83
85
Non Current Liabilities
0
0
0
4
6
11
13
9
Total Equity
1
1
1
1
2
24
38
39
Reserve & Surplus
0
1
1
1
2
12
14
14
Share Capital
0
0
0
0
0
12
24
24

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
6
8
-13
Investing Activities
0
0
0
0
0
0
Operating Activities
-3
-2
3
-21
-5
-9
Financing Activities
3
3
-3
27
14
-4

Share Holding

% Holding
Jul 2022
Sept 2022
Mar 2023
Sept 2023
Dec 2023
Mar 2024
Sept 2024
Mar 2025
Sept 2025
Promoter
100.00 %
66.56 %
66.56 %
57.19 %
9.98 %
9.98 %
9.98 %
9.98 %
9.98 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
31.32 %
31.36 %
40.33 %
63.07 %
63.07 %
81.82 %
71.21 %
73.74 %
Others
0.00 %
2.12 %
2.08 %
2.48 %
26.95 %
26.95 %
8.20 %
18.81 %
16.28 %
No of Share Holders
7
1,178
992
1,078
1,807
1,807
2,652
1,997
1,742

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
03 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
03 Jan 2024 10.02 8.92
12 Feb 2024 RIGHTS Rights
13:12
12 Feb 2024 9.81 12.51
27 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Aug 2024 7.73 8.89
11 Dec 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Dec 2024 7.74 7.74
04 Apr 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
04 Apr 2025 13.38 14.76
07 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Jul 2025 23.28 24.13
30 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Aug 2025 20.20 19.00
26 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 Nov 2025 19.90 17.80

Announcements

Announcement under Regulation 30 (LODR)-AllotmentNov 29, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday 29Th November 2025Nov 29, 2025
Statement Of Deviation And VariationNov 26, 2025
Integrated Filing (Financial) For The Half Year Ended On 30Th September 2025Nov 26, 2025
Unaudited Financial Results For The Half Year Ended On 30Th September 2025.Nov 26, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Wednesday 26Th November 2025Nov 26, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 19, 2025
Board Meeting Intimation for Intimation Of Rescheduling Of Board MeetingNov 19, 2025
Board Meeting Intimation for Intimation Of Rescheduling Of Board MeetingNov 14, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday 14Th November 2025Nov 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Closure of Trading WindowSep 30, 2025
Board Meeting Outcome for Outcome Of Board MeetingSep 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Tuesday 9Th September 2025Sep 09, 2025
Voting Results Of The Annual General MeetingSep 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 30, 2025
Intimation Of In-Principle Approval For Issue Of 76605000 Warrants Convertible Into Equity Shares Of M/S. Dipna Pharmachem Limited (The Company) Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure RequiremeAug 30, 2025
Undertaking Regarding Appointment Of Monitoring Agency - Preferential Issue Of Equity SharesAug 28, 2025
Intimation Of Book Closure Pursuant To Regulation 42 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation 2015Aug 08, 2025
Outcome Of Board Meeting & Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 08, 2025
Reg. 34 (1) Annual Report.Aug 08, 2025
Notice Of Annual General Meeting To Be Held On 30Th August 2025Aug 08, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Outcome Of The Board MeetingJul 07, 2025
Integrated Filing (Finance)Jul 07, 2025
Financial Results For Half Year And Year Ended On 31St March 2025Jul 07, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 7Th July 2025Jul 07, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday 7Th July 2025Jul 02, 2025
Outcome Of The Board Meeting And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 May 03, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMay 03, 2025
Board Meeting Outcome for Outcome Of The Board Meeting And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Submission Of Voting Results Of Extra Ordinary General Meeting Of The Company Under Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 07, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 07, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMApr 04, 2025
Closure of Trading WindowMar 29, 2025
Notice Of Extra-Ordinary General Meeting (EGM) Of The CompanyMar 13, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Wednesday 12Th March 2025Mar 12, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 07, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Monday 24Th February 2025Feb 24, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 11, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday 6Th February 2025Feb 06, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Clarification Sought On Significant Movement In PriceDec 30, 2024
Clarification sought from Dipna Pharmachem LtdDec 30, 2024
Results-Delay in Financial ResultsDec 18, 2024
Results-Delay in Financial ResultsDec 11, 2024

Technical Indicators